STL Volume 28 Number 1

STL Volume 28 Number 1
3 POSTS 0 COMMENTS
Purchase PDF for $2.79
a crop up image of woman scratching her dry skin (Tralokinumab)

Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults

Tralokinumab is an effective and safe treatment for adult patients with moderate-to-severe AD. It may be used alone or in combination with TCS. This biologic can be considered first-line treatment after failure of or intolerance to topical therapies.
image of medical research being done on antibiotic culture in the lab

Antibiotic Resistance in Dermatology Part 1: Mechanisms of Resistance

Awareness of the molecular mechanisms of antibiotic resistance among bacteria is necessary to understand the etiology of antibiotic resistance in dermatology at the most basic level.
Image of doctor preparing a treatment injection

Update on Drugs & Devices: January – February 2023

Update covering: Deucravacitinib tablets (Sotyktu™), mRNA vaccine + pembrolizumab IV combination therapy (mRNA-4157/V940 + Keytruda®), Adalimumab-aacf SC injection (Idacio®), Dupilumab for SC injection (Dupixent®), and Spesolimab IV injection (Spevigo®).

POPULAR

Advertisement